Cathay Biotech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	3,149	2,819	2,067	2,332	2,296	1,488
Other Revenue	138.84	138.84	47.17	108.67	67.67	9.49
Revenue	3,288	2,958	2,114	2,441	2,363	1,497
Revenue Growth (YoY)	18.96%	39.91%	-13.39%	3.28%	57.86%	-21.87%
Cost of Revenue	2,280	2,121	1,535	1,612	1,526	808.77
Gross Profit	1,008	836.44	579.23	829.2	837.21	688.42
Selling, General & Admin	229.38	222	221.61	232.28	175.11	143.25
Research & Development	243.11	233.34	189.13	187.71	133.53	84.3
Other Operating Expenses	15.05	13.83	9.21	-4.09	22.94	10.45
Operating Expenses	500.29	472.51	413.68	422.59	337.95	241.23
Operating Income	507.43	363.93	165.55	406.61	499.25	447.19
Interest Expense	-13.95	-27.43	-32.17	-20.01	-16.29	-3.86
Interest & Investment Income	185.57	160.75	219.77	236.78	229.61	52.18
Earnings From Equity Investments	-8.95	-8.95	-7.82	-3.71	-	-
Currency Exchange Gain (Loss)	36.73	36.73	29.59	82.97	-14.14	-18.26
Other Non Operating Income (Expenses)	-7.23	-6.04	-5.7	-4.61	-0.59	-0.32
EBT Excluding Unusual Items	699.61	518.99	369.22	698.03	697.84	476.93
Gain (Loss) on Sale of Investments	6.45	-	-	-	-	9.15
Gain (Loss) on Sale of Assets	7.13	0.42	-0.01	0.07	-	-
Asset Writedown	-74.27	-0.05	-0.26	-0.02	-0.06	-1.15
Other Unusual Items	25.14	28.66	79.97	-2.09	26.66	35.85
Pretax Income	664.06	548.02	448.92	695.99	724.45	520.79
Income Tax Expense	105	73.43	40.39	83.34	90.94	63.45
Earnings From Continuing Operations	559.06	474.59	408.54	612.65	633.51	457.34
Minority Interest in Earnings	35.4	14.37	-42.01	-59.39	-38.79	0.33
Net Income	594.46	488.96	366.52	553.27	594.72	457.67
Net Income to Common	594.46	488.96	366.52	553.27	594.72	457.67
Net Income Growth	49.43%	33.41%	-33.75%	-6.97%	29.94%	-4.43%
Shares Outstanding (Basic)	648	582	582	582	583	543
Shares Outstanding (Diluted)	648	582	582	582	583	543
Shares Change (YoY)	10.81%	0.05%	-0.10%	-0.11%	7.38%	6.91%
EPS (Basic)	0.92	0.84	0.63	0.95	1.02	0.84
EPS (Diluted)	0.92	0.84	0.63	0.95	1.02	0.84
EPS Growth	34.86%	33.33%	-33.68%	-6.86%	21.01%	-10.61%
Free Cash Flow	-327.46	-22.38	-1,000	-3,395	-880.49	-248.15
Free Cash Flow Per Share	-0.51	-0.04	-1.72	-5.83	-1.51	-0.46
Dividend Per Share	0.400	0.400	0.190	0.180	0.321	0.571
Dividend Growth	110.53%	110.53%	5.56%	-43.99%	-43.75%	-
Gross Margin	30.65%	28.28%	27.40%	33.97%	35.42%	45.98%
Operating Margin	15.43%	12.30%	7.83%	16.66%	21.12%	29.87%
Profit Margin	18.08%	16.53%	17.34%	22.66%	25.16%	30.57%
Free Cash Flow Margin	-9.96%	-0.76%	-47.32%	-139.06%	-37.25%	-16.57%
EBITDA	846.01	679.85	451.26	671.73	667.79	565.51
EBITDA Margin	25.73%	22.98%	21.34%	27.52%	28.25%	37.77%
D&A For EBITDA	338.57	315.92	285.72	265.12	168.54	118.32
EBIT	507.43	363.93	165.55	406.61	499.25	447.19
EBIT Margin	15.43%	12.30%	7.83%	16.66%	21.12%	29.87%
Effective Tax Rate	15.81%	13.40%	9.00%	11.97%	12.55%	12.18%
Revenue as Reported	3,288	2,958	2,114	2,441	2,363	1,497

Source: S&P Global Market Intelligence. Standard template. Financial Sources.